Cancer Institute A national cancer institute
designated cancer center

David Miklos

Publication Details

  • Recombinant antigen microarrays for serum/plasma antibody detection.

    Wadia PP, Sahaf B, Miklos DB. Methods Mol Biol. 2011: 723 81-104

    Recombinant antigen arrays represent a new frontier in parallel analysis of multiple immune response profiles requiring only minute blood samples. In this article, we review the benefits and pitfalls of recombinant antigen microarrays developed for multiplexed antibody quantification. In particular, we describe the development of antigen arrays presenting a set of Y chromosome-encoded antigens, called H-Y antigens. These H-Y antigens are immunologically recognized as minor histocompatibility antigens (mHA) following allogeneic blood and organ transplantation. Clinically relevant B-cell responses against H-Y antigens have been demonstrated in male patients receiving female hematopoietic stem cell grafts and are associated with chronic graft versus host development. This chapter discusses our recombinant antigen microarray methods to measure these clinically relevant allo-antibodies.

    PubMedID: 21370061

Stanford Medicine Resources:

Footer Links: